Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
3,783,974
-
Share change
-
-1,910,088
-
Total reported value
-
$16,902,446
-
Put/Call ratio
-
714%
-
Price per share
-
$4.45
-
Number of holders
-
38
-
Value change
-
-$48,644,584
-
Number of buys
-
21
-
Number of sells
-
16
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q2 2021
As of 30 Jun 2021,
DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,783,974 shares.
The largest 10 holders included
VANGUARD GROUP INC, Manatuck Hill Partners, LLC, Stonepine Capital Management, LLC, Ikarian Capital, LLC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, Corriente Advisors, LLC, MARSHALL WACE, LLP, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
38
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.